Arcus Biosciences - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $79,989.06 +0.45%
Ethereum $2,503.05 +2.03%
BNB $757.25 +0.52%
Optimism $0.11 +8.81%
Arbitrum $0.19 +45.71%
Solana $106.57 +4.01%
Polygon $0.22 +2.77%
Cosmos $1.60 +4.12%
Avalanche $7.69 +2.53%

Bitcoin $79,989.06 +0.45%
Ethereum $2,503.05 +2.03%
BNB $757.25 +0.52%
Optimism $0.11 +8.81%
Arbitrum $0.19 +45.71%
Solana $106.57 +4.01%
Polygon $0.22 +2.77%
Cosmos $1.60 +4.12%
Avalanche $7.69 +2.53%

Arcus Biosciences

company

Investors

Number of Lead Investors

Number of Investors

3

18

Arcus Biosciences is funded by 18 investors. Gilead Sciences and GV are the most recent investors.

Investor Name	Lead Investor	Funding Round
Gilead Sciences	Yes	Post-IPO Equity
GV	Yes	Series C
Aisling Capital	-	Series C
Biotechnology Value Fund	-	Series C
Celgene	-	Series C
Decheng Capital	-	Series C
Droia Ventures	-	Series C
EcoR1 Capital	-	Series C
Foresite Capital	-	Series C
Hillhouse Capital Group	-	Series C
Invus	-	Series C
Leerink Partners	-	Series C
Taiho Ventures	-	Series C
The Column Group	-	Series C
Wellington Management	-	Series C
Novartis	-	Series B
RTA Capital	-	Series B
Stanford University	-	Series B